Overview of high-risk Food and Drug Administration recalls for cosmetics and personal care products from 2002 to 2016

被引:7
|
作者
Janetos, Timothy M. [1 ]
Akintilo, Lisa [2 ]
Xu, Shuai [2 ]
机构
[1] Northwestern Univ, Dept Ophthalmol, McGaw Med Ctr, Chicago, IL 60611 USA
[2] Northwestern Univ, McGaw Med Ctr, Dept Dermatol, Chicago, IL 60611 USA
关键词
cosmetic recalls; cosmetic safety; Food and Drug Administration; moisturizers; personal care products; sunscreens; UNIT;
D O I
10.1111/jocd.12824
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: There have been several recent controversies surrounding cosmetic products that have impacted health. Dermatologists are often the first to encounter these issues, and recalls are one metric of a safety profile of cosmetics and their impact on health. Objective: To analyze all recalls of cosmetic and personal care products from 2002 to 2016. Methods: This observational study describes all FDA cosmetic and personal care product recalls, acquired via a Freedom of Information Act request, from 2002 to 2016. The total number of Class I, Class II, and Class III recalls, number and origin of manufacturers, number of products affected, and main reason for recall were collected. Results: A total of 14 Class I, 266 Class II, and 33 Class III recalls were recorded. Baby products comprised the largest product category accounting for 24% of all recalls (76/313). 76% of recalls were due to bacterial contamination (237/313), followed by unapproved components, labeling issues, and skin irritation. The 14 Class I recalls accounted for 1.9 million products in distribution. Conclusions: Cosmetic recalls impacted millions of products and had the potential to cause serious harm. Dermatologists have the ability to strengthen public safety by reporting adverse events, encouraging recalls of harmful products, and lobbying through dermatology organizations for meaningful change to current cosmetic regulation.
引用
收藏
页码:1361 / 1365
页数:5
相关论文
共 35 条
  • [1] Adverse events reported to the Food and Drug Administration from 2004 to 2016 for cosmetics and personal care products marketed to newborns and infants
    Cornell, Erika
    Kwa, Michael
    Paller, Amy S.
    Xu, Shuai
    PEDIATRIC DERMATOLOGY, 2018, 35 (02) : 225 - 229
  • [2] Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products
    Kwa, Michael
    Welty, Leah J.
    Xu, Shuai
    JAMA INTERNAL MEDICINE, 2017, 177 (08) : 1202 - 1204
  • [3] Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety
    Janetos, Timothy M.
    Ghobadi, Comeron W.
    Xu, Shuai
    Walter, Jessica R.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (01) : 42 - +
  • [4] Ocular Adverse Effects of Over-the-Counter Cosmetics and Personal Care Products Reported to the Food and Drug Administration
    Zhu, Aretha
    Aftab, Owais M.
    Mahajan, Jasmine
    Burkat, Cat N.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2025, 41 (01): : 61 - 66
  • [5] US Food and Drug Administration recalls of cosmetic and personal products from 2011 to 2023: A cross-sectional study
    Venkatesh, Kaushik P.
    Kadakia, Kushal T.
    Akbarpour, Ashkan
    Nambudiri, Vinod E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (01) : 179 - 181
  • [6] Approval-Adjusted Recall Rates of High-Risk Medical Devices from 2002-2016 Across Food and Drug Administration Device Categories
    Ghobadi, Comeron W.
    Janetos, Timothy M.
    Tsai, Shelun
    Beaumont, Jennifer L.
    Welty, Leah
    Walter, Jessica R.
    Xu, Shuai
    ISSUES IN LAW & MEDICINE, 2019, 34 (01) : 77 - 92
  • [7] Recalls of Moderate- and High-Risk Otolaryngologic Devices Approved by the US Food and Drug Administration, 2003-2019
    Talati, Ish A.
    Parsa, Keon M.
    Gao, William Z.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2022, 167 (05) : 832 - 838
  • [8] High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
    Pathak, Kavya
    Narang, Claire
    Hwang, Thomas J.
    Espinoza, Juan C.
    Bourgeois, Florence T.
    JAMA PEDIATRICS, 2023, 177 (01) : 98 - 100
  • [9] Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study
    Mooghali, Maryam
    Ross, Joseph S.
    Kadakia, Kushal
    Dhruva, Sanket S.
    MEDICAL DEVICES-EVIDENCE AND RESEARCH, 2023, 16 : 111 - 122
  • [10] Postmarket Modifications of High-Risk Therapeutic Devices in Otolaryngology Cleared by the US Food and Drug Administration
    Rathi, Vinay K.
    Ross, Joseph S.
    Samuel, Andre M.
    Mehra, Saral
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 153 (03) : 400 - 408